The old guard: Age-related changes in microglia and their consequences

https://doi.org/10.1016/j.mad.2021.111512Get rights and content
Under a Creative Commons license
open access

Highlights

  • The aging process encompasses the development of a heightened inflammatory status in the brain.

  • Environmental triggers, like stress, infection and poor diet contribute to neuroimmune senescence and “inflammaging”.

  • Microglia in the aged brain experience an augmented inflammatory profile and impaired defensive and housekeeping roles.

  • Microglia dysfunction impacts normal brain homeostasis, promoting circuitry dysfunction and cognitive impairment.

  • Better control of our diet, physical activity and stress levels are cost-effective strategies to promote healthy aging.

Abstract

Among all major organs, the brain is one of the most susceptible to the inexorable effects of aging. Throughout the last decades, several studies in human cohorts and animal models have revealed a plethora of age-related changes in the brain, including reduced neurogenesis, oxidative damage, mitochondrial dysfunction and cell senescence. As the main immune effectors and first responders of the nervous tissue, microglia are at the center of these events. These cells experience irrevocable changes as a result from cumulative exposure to environmental triggers, such as stress, infection and metabolic dysregulation. The age-related immunosenescent phenotype acquired by microglia is characterized by profound modifications in their transcriptomic profile, secretome, morphology and phagocytic activity, which compromise both their housekeeping and defensive functions. As a result, aged microglia are no longer capable of establishing effective immune responses and sustaining normal synaptic activity, directly contributing to age-associated cognitive decline and neurodegeneration. This review discusses how lifestyle and environmental factors drive microglia dysfunction at the molecular and functional level, also highlighting possible interventions to reverse aging-associated damage to the nervous and immune systems.

Abbreviations

AD
Alzheimer’s Disease
AHR
aryl hydrocarbon receptor
BAM
barrier-associated macrophages
BBB
blood-brain barrier
CCL2
C-C motif chemokine ligand 2
CR
caloric restriction
CRP
c-reactive protein
CSF1R
colony stimulating factor 1 receptor
C1q
complement component 1q
C3
complement component
DAM
disease-associated microglia
DC
dendritic cell
DHA
docosahexaenoic acid
EPA
eicosapentaenoic acid
FTLD
frontotemporal lobar degeneration
GC
glucocorticoids
HAM
human Alzheimer’s disease microglia
HFD
high-fat diet
HMGB1
high mobility group box protein 1
HPA axis
hypothalamic-pituitary-adrenal axis
HSV1
herpes simplex virus 1
IBA-1
ionized calcium-binding adaptor protein 1
IFA
interfollicular area
IFN-I
interferon type 1
IFN-III
interferon type 3
IFN-β
interferon beta
IFN- γ
interferon gama
IL-6
interleukin 6
IL-1β
interleukin 1beta
IL-4
interleukin 4
IL-8
interleukin 8
IL-12
interleukin 12
IL-10
interleukin 10
IL-17
interleukin 17
LDAM
lipid-droplet accumulating microglia
LPS
lipopolysaccharide
M-CSF
macrophage colony-stimulating factor
MGnD
microglial neurodegenerative phenotype
MHCII
major histocompatibility complex class II
MIA
maternal immune activation
mPFC
medial prefrontal cortex
NF-Kb
nuclear factor kappa B
NK
natural killer cells
n-3 PUFAs
omega-3 polyunsaturated fatty acids
OPCs
oligodendrocyte progenitor cells
pDCs
plasmacytoid dendritic cells
P3C
pam3CysSerLys4ROS - reactive oxygen species
SASP
senescence-associated secretory phenotype
TCR
T cell receptor
TDP-43
TAR DNA-binding protein 43
TGF-β
transforming growth factor β
Th2
helper T cells type 2
TLR
toll-like receptor
TNF-α
tumor necrosis factor α
TREM1
triggering receptor expressed on myeloid cells 1
TSPO
translocator protein

Keywords

Aging
Stress
Infection
Cognitive decline
Neuroimmune system
Microglia
Inflammation

Cited by (0)